Hong Kong Stocks Under Pressure Near-Term, Manulife’s Li Says

Marco Li, Hong Kong-based portfolio manager at Manulife Asset Management, which oversees $238 billion globally, comments on the outlook for Hong Kong stocks in the wake of an outbreak of a new strain of deadly bird flu in China.

“It’s tough because in investors’ minds a lot of people can remember SARS in 2003. There’s a bit of fear from what potentially can happen, especially in Hong Kong, because they do remember the magnitude of it.

‘‘Friday was clearly a bit of a panic sell, but it’s still early to tell if the decline was premature.

‘‘Some was trigger-happy-type of selling and you’ll get some fundamental buying support to some of the overreactions.

‘‘There’s going to be near-term pressure no matter how you cut it. You have this overhang now, and until you get clarity, people will see that as a potential risk for further exacerbation.

‘‘With some of the yen devaluing -- there’s a liquidity chasing that particular market so it diverts some of the attention away from North Asia as well as ASEAN. It creates a new liquidity shift.

‘‘In any type of market correction, you want to stay with the quality names that have liquidity to give you flexibility as an investor. There are longer-term inflation concerns, and equities are still the place to be.’’

To contact the reporter on this story: Kana Nishizawa in Hong Kong at knishizawa5@bloomberg.net.

To contact the editor responsible for this story: Nick Gentle at ngentle2@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.